Opinion
Video
Benjamin M. Brucker, MD, outlines considerations surrounding pre-procedure urinalysis, prophylactic periprocedural antibiotics, and optimal dosing regimens for onabotA administration.
There are several day-of considerations for administering onabotulinumtoxinA (Botox). These were detailed in the recent publication, “Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.”1
In an interview with Urology Times®, co-author Benjamin M. Brucker, MD, specifically discussed considerations surrounding pre-procedure urinalysis, prophylactic periprocedural antibiotics, and optimal dosing regimens for onabotA administration.
Brucker is a urologist and urogynecologist at NYU Langone Health in New York, New York.
REFERENCE
1. Eilber KS, Brucker BM, Pezzella A, et al. Expert opinions on best practices for overactive bladder management with onabotulinumtoxinA. Toxins (Basel). 2025;17(4):207.doi:10.3390/toxins17040207
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.